AzTrials
AzTrials

DepressionHappy@HomeNCT04267289

Happy@Home: Delivering iCBT With Homecare Workers to At-Home Seniors

A study testing Beating the Blues in people with Depression, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Depression is one of the most common and debilitating conditions among older adults. At-home seniors, also called homebound seniors, are older adults who are confined to a bed or chair and are unable to get about outdoors. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Depression
What is being tested?
Beating the Blues
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteUnited States
Study dates
30 May 2019to 30 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 60 years of age
  • have received home care for ≥ 1 month and anticipate continued care for ≥ 3 months
  • have at least mild depressive symptoms (PHQ-9≥5)
  • speak English.

Who cannot join

  • Currently receiving psychotherapy
  • Have a psychotic disorder (BPRS)
  • Have active suicidal ideation based on endorsement of PHQ-9 item 9 (other than not at all)
  • Severe cognitive impairment, assessed as having ≥ 3 errors on the 6-item Mini mental state exam
  • Have a planned hospital admission in the next 3 months of enrollment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Michigan

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: Happy@Home: Delivering Internet-based Cognitive Behavioral Therapy With Homecare Workers to At-Home Seniors

Depression is one of the most common and debilitating conditions among older adults. At-home seniors, also called homebound seniors, are older adults who are confined to a bed or chair and are unable to get about outdoors. Internet-based CBT (iCBT) delivers CBT via websites or dedicated apps on mobile devices or tablets. iCBT can be self-administered or guided by a therapist. Its strengths include low-cost, accessibility, and ability to tailor to individual needs while maintaining fidelity. Despite its potential, iCBT trials have rarely included older adults. Those that included older adults showed that they tended to report more technological challenges but they benefited from the intervention as much as younger adults did. As far as we know, studies have not yet tested the feasibility and preliminary effects of iCBT with a diverse group of at-home seniors receiving non-skilled home care. This study explores the feasibility and acceptability of delivering iCBT to a sample of at-home seniors who receive non-skilled home care. Home care workers who care for these seniors are recruited to provide assistance for completing iCBT. We hypothesize that iCBT is an acceptable and feasible intervention for treating depression among at-home seniors.

Read the detailed description

Depression is one of the most common and debilitating conditions among older adults. At-home seniors, also called homebound seniors, are older adults who are confined to a bed or chair and are unable to get about outdoors. Medical morbidity, disability, cognitive impairment, pain, and social isolation are known risk factors for depression that are prevalent among at-home seniors. Epidemiological and community-based studies have consistently documented a high prevalence of depression among at-home seniors. However, depression treatment is often inaccessible to at-home seniors. The majority of at-home seniors with depression do not receive adequate treatment, with the dominant treatment modality being medication. Successfully treating late-life depression requires a multi-component treatment program beyond medication. Besides, medication non-adherence is common due to concerns of side effects and preferences for other treatment modalities such as counseling. However, office-based psychotherapy is out of reach for at-home seniors who often require assistance for transportation. In addition, older adults prefer home-based treatment and counseling, and consideration of their preference may lead to better treatment outcomes.

Online therapy (iCBT) is an evidence-based approach for treating depression. Cognitive-behavioral therapy (CBT) is the gold standard of psychotherapy for depression in both young and older adults. Internet-based CBT (iCBT) delivers CBT via d websites or dedicated apps on mobile devices or tablets. iCBT can be self-administered or guided by a therapist. Its strengths include low-cost, accessibility, and ability to tailor to individual needs while maintaining fidelity. Meta-analyses have shown that iCBT is equivalent to face-to-face CBT in its effectiveness for treating depression. Emerging evidence suggests that iCBT may actually be more effective for older adults, because they are more likely to adhere to treatment than their younger counterparts. Despite the benefits of iCBT, most older adults do not use iCBT, possibly due to limited opportunities accessing iCBT programs and technological challenges.

This project explores the feasibility of implementing iCBT in non-skilled home care. Home care workers provide personal care and companionship to older adults in need of assistance with daily activities, housekeeping, medication management, and transportation. Home care is provided full-time, part-time, intermittently, or even around the clock to address the recipient's long-term care needs. Home-based care provides a naturalized and accessible setting, and frequent home visits over an extended period offer opportunities for prolonged engagement and symptom monitoring. Research shows that iCBT programs with human support are more effective than self-guided programs. For at-home seniors, home care workers represent an untapped resource of human support and can be trained to provide technical assistance for at-home seniors with limited computer literacy, addressing technological challenges associated with iCBT use. Moreover, home care workers can facilitate the completion of behavioral activation activities (e.g., drive a client to attend a social activity), which is critical in realizing the effectiveness of CBT. In addition, participation in training and intervention may also benefit the home care workers themselves by improving job satisfaction, pride, and retention. However, Studies have not tested iCBT with at-home seniors receiving home care. Protocols for implementing iCBT in home care also do not exist. Issues regarding screening, supervision, and referrals need to be addressed and standardized. In addition, we need to develop strategies to address implementation barriers at the patient, provider, and organization levels to achieve sustained impact.

This pilot feasibility study is a pragmatic trial of iCBT among a sample of diverse at-home seniors receiving non-skilled home care. Guided by the Replicating Effective Programs framework, this study aims to develop materials to package an existing, evidence-based iCBT program called Beating the Blues for testing in a sample of at-home seniors receiving home care. The primary aim of the study is to test whether iCBT is an acceptable treatment modality for at-home seniors with varying levels of technology competency. An exploratory aim is to examine whether it is feasible to train home care workers to assist seniors with iCBT completion. Findings from this pilot study will gather information regarding barriers to implement iCBT in non-skilled home care at the provider- (home care workers) and the patient- (at-home seniors) levels. If the results from this study are promising, subsequent efforts will be devoted to address implementation barriers at the organizational (home care agencies) level.

The study is a single-group open trial. Study materials (measurements, participant workbook) will be piloted tested with 2 subjects, who will not participate in the full trial. The targeted sample size for the full trial is 28. A sample size of 23 provides a power of 0.95 to detect a significant effect size of d=.8 from paired-sample t-test (G*Power, 3.1 version). A proposed sample size of 28 therefore has sufficient power to detect the projected effect size.

Study subjects will be recruited from home-care agencies, meals-on-wheels, and senior apartment buildings in Ann Arbor and surrounding areas.

After being screened and consented, subjects will receive a comprehensive baseline assessment. Subjects have the choice of receiving assistance from their home care worker, assistance from a member of the research team, or work on the iCBT program on their own. If subjects prefer to work on the iCBT program with their home care workers, their workers will also been consented and receive a training. After their workers finish the required training, subjects will then start treatment. Research team will supply a tablet and prepaid data packages to subjects if they don't have access to a working device or internet package. Subjects are told that they have 3 months to use the online program. Subjects will receive a comprehensive post-test assessment once they complete the entire program or at the end of the 3-month period, whichever occurs first. Subjects will also be asked to participate in a short individual interview during post-test. All assessments with subjects will take place at their home. The structured part of the comprehensive baseline and post-test includes three parts: an online self-administered survey, a clinical interview, and Montreal Cognitive Assessment (MoCA) test for cognitive impairment using the MoCA app. In addition to these scheduled assessments, Beating the Blues, the iCBT program used in the study, has built-in assessments (PHQ-9 and GAD-7) at the start of session 1 and the end of session 3, 5, 7, \& 8.

Survey data will be recorded and managed using Qualtrics.

Post-treatment analysis will involve an intention-to-treat design where missing data are addressed by carrying forward data previously collected. Primary outcomes include Patient Health Questionnaire (PHQ-9) for depressive symptoms, number of sessions completed, and program satisfaction/acceptability. Difference in PHQ-9 between session 1 and post-test will be calculated and tested. Session 1 PHQ-9 score will be used to assure consistency in time lapsed up until post-test. Secondary outcomes include Generalized Anxiety Disorder (GAD-7) for anxiety and Montreal Cognitive Assessment (MoCA) for cognitive impairment. Difference in GAD-7 between session 1 and post-test will be calculated and tested. Difference in MoCA score between baseline and post-test will be tested. Paired-sample t-test will be used to detect statistically significant difference. Effect sizes (Cohen's d) and 95% confidence intervals will be calculated. Statistical analyses will be conducted using Stata 15.1 SE version.

This study is supported by an Investigator-Initiated Grant from the Blue Cross Blue Shield of Michigan Foundation and a grant from the Michigan Department of Health and Human Services.

Conditions
Depression
Being tested
Beating the Blues
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Beating the BluesBehavioural

    Also called Internet based cognitive behavioral therapy

    Automated, cognitive behavioral therapy delivered via a website. There are 8 sessions, each taking one to 1.5 hours to complete. Sessions are prerecorded and sequenced. Sessions are based on the principles of cognitive behavioral therapy and include techniques such as cognitive restructuring and behavioral activation. The entire program takes about 8 to 12 weeks to complete.

Study groups in NCT04267289
Study groupRoleWhat they receive
iCBT treatment groupExperimentalSubjects were given license to use Beating the Blues, a commercially available iCBT program. Subjects were given 3 months to use the program.
Receives: Behavioral: Beating the Blues

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Health Questionnaire-9 Items (PHQ-9)

    PHQ-9 for depressive symptoms, total score ranges from 0 to 27, higher scores indicate worse depressive symptoms

    Measured: Change from baseline PHQ9 at end of treatment (3 months after the start of treatment)

  2. # of sessions completed

    # of Beating the Blues sessions completed at the end of 3 months

    Measured: Up to 3 months after the start the treatment

  3. Acceptability

    Treatment acceptability scale, has a total of 10 questions, total score ranges from 10 to 50, higher scores indicate higher acceptability

    Measured: Up to 3 months after the start the treatment

  4. Satisfaction with the treatment program

    self rated satisfaction with the program, score ranges from 1 to 10. Higher score indicates higher satisfaction.

    Measured: Up to 3 months after the start the treatment

Secondary outcomes (3)
  1. Generalized Anxiety Disorder-7 (GAD-7)

    Anxiety symptoms assessment, total score ranges from 0 to 21, higher score indicating worse anxiety symptoms

    Measured: Change from baseline GAD7 at end of treatment (3 months after the start of treatment)

  2. Montreal Cognitive Assessment (MoCA)

    Cognitive impairment assessment. Total score ranges from 0 to 30. Higher score indicates better cognition and less cognitive impairment.

    Measured: Change from baseline MoCA at end of treatment (3 months after the start of treatment)

  3. EQ5D-5L

    This measures health related quality of life. EQ5D-5L has five questions and total score is not a simple sum of questions. Scores needs to be converted into utility scores based on population norms. Final utility index score ranges from 0 to 1 (1-sum of raw utility scores), with a higher score indicating better health-related quality of life.

    Measured: Change from baseline EQ5D at end of treatment (3 months after the start of treatment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2020
  2. Study start30 May 2019
  3. Primary completion30 Mar 2020
  4. Study completion30 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04267289
Sponsor's protocol ID
2748II
Acronym
Happy@Home
Status last verified
May 2020
First submitted
7 Feb 2020
Last updated
11 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Xiang X, Kayser J, Sun Y, Himle J. Internet-Based Psychotherapy Intervention for Depression Among Older Adults Receiving Home Care: Qualitative Study of Participants' Experiences. JMIR Aging. 2021 Nov 22;4(4):e27630. doi: 10.2196/27630.

    PubMed 34813491

Questions about this trial

What is this clinical trial studying?

A study testing Beating the Blues in people with Depression, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Health Questionnaire-9 Items (PHQ-9) (time frame: Change from baseline PHQ9 at end of treatment (3 months after the start of treatment)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04267289, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in